Adeno-associated virus based cardiomyopathy gene therapyies - Nuevocor
Alternative Names: Lamin A/C dilated cardiomyopathy (LMNA DCM) gene therapy - Nuevocor; LMNA DCM gene therapy - NuevocorLatest Information Update: 24 Jun 2021
At a glance
- Originator Nuevocor
- Class Gene therapies; Heart failure therapies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Cardiomyopathies